Briplatin and malignant neoplasm progression Patient Reports February 12, 2012

Briplatin Side Effects Report #5857402-6
Briplatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 21, 2008. Male patient, 77 years of age, weighting 132.3 lb, was diagnosed with pleural mesothelioma malignant, febrile neutropenia, bone marrow failure and was treated with Briplatin. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, bone marrow failure, febrile neutropenia, interstitial lung disease, liver disorder, malignant neoplasm progression, multi-organ failure. Briplatin dosage: unknown. During the same period patient was treated with ALIMTA, PAZUCROSS, MEROPEN, PANVITAN, CYANOCOBALAMIN, AMARYL, BASEN. Patient was hospitalized. Patient died on 05/13/2008.

Briplatin Side Effects Report #5563302-1
Briplatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 14, 2007. Male patient, 75 years of age, weighting 123.5 lb, was diagnosed with pleural mesothelioma malignant and was treated with Briplatin. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, malignant neoplasm progression, neutrophil count decreased, platelet count decreased, renal impairment, shock, white blood cell count decreased. Briplatin dosage: unknown. During the same period patient was treated with ALIMTA, PANVITAN, MASBLON H, KYTRIL, DECADRON, ZANTAC, FOSMICIN, PRIMPERAN. Patient was hospitalized and became disabled. Patient died on 09/14/2007.

Briplatin Side Effects Report #5605483-7
Briplatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 23, 2008. Male patient, 75 years of age, weighting 123.5 lb, was diagnosed with pleural mesothelioma malignant and was treated with Briplatin. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, diarrhoea, lymphocyte count decreased, malignant neoplasm progression, nausea , neutrophil count decreased, platelet count decreased, renal impairment. Briplatin dosage: unknown. During the same period patient was treated with ALIMTA, PANVITAN, MASBLON H, KYTRIL, DECADRON, ZANTAC, FOSMICIN, PRIMPERAN. Patient was hospitalized and became disabled. Patient died on 09/14/2007.

Briplatin Side Effects Report #5608804-4
Briplatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 30, 2008. Male patient, 75 years of age, weighting 123.5 lb, was diagnosed with pleural mesothelioma malignant and was treated with Briplatin. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, diarrhoea, lymphocyte count decreased, malignant neoplasm progression, nausea , neutrophil count decreased, platelet count decreased, renal function test abnormal. Briplatin dosage: unknown. During the same period patient was treated with ALIMTA, PANVITAN, MASBLON H, KYTRIL, DECADRON, ZANTAC, FOSMICIN, PRIMPERAN. Patient was hospitalized and became disabled. Patient died on 09/14/2007.


Briplatin Side Effects Report #5593461-6
Briplatin side effect was reported by a Health Professional from JAPAN on Jan 11, 2008. Male patient, 72 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Briplatin. After drug was administered, patient experienced the following side effects: anaemia, c-reactive protein increased, headache , hepatic function abnormal, hypoalbuminaemia, malignant neoplasm progression, nausea , platelet count decreased, renal impairment. Briplatin dosage: 75 MG TAKEN ON 04-APR-2007 TO 04-APR-2007. During the same period patient was treated with ALIMTA, PANVITAN, CYANOCOBALAMIN, MYSLEE, LOXONIN, MEDICON, CYTOTEC, URSO. Patient was hospitalized. Patient died.

Briplatin Side Effects Report #5593596-8
Briplatin side effect was reported by a Health Professional from JAPAN on Jan 11, 2008. Male patient, 72 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Briplatin. After drug was administered, patient experienced the following side effects: anaemia, c-reactive protein increased, headache , hepatic function abnormal, hypoalbuminaemia, malignant neoplasm progression, nausea , platelet count decreased, renal impairment. Briplatin dosage: 75 MG TAKEN ON 04-APR-2007 TO 04-APR-2007. During the same period patient was treated with ALIMTA, AVASTIN, PANVITAN, CYANOCOBALAMIN, MYSLEE, LOXONIN, MEDICON, CYTOTEC. Patient was hospitalized. Patient died.

Briplatin Side Effects Report #5602596-0
Briplatin side effect was reported by a Health Professional from JAPAN on Jan 22, 2008. Male patient, 72 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Briplatin. After drug was administered, patient experienced the following side effects: anaemia, c-reactive protein increased, headache , hepatic function abnormal, hypoalbuminaemia, malignant neoplasm progression, nausea , platelet count decreased, renal impairment. Briplatin dosage: 75 MG TAKEN ON 04-APR-2007 TO 04-APR-2007. During the same period patient was treated with ALIMTA, PANVITAN, CYANOCOBALAMIN, MYSLEE, LOXONIN, MEDICON, CYTOTEC, URSO. Patient was hospitalized. Patient died.

Briplatin Side Effects Report #5599882-X
Briplatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2008. Male patient, 67 years of age, weighting 101.4 lb, was diagnosed with pleural mesothelioma malignant and was treated with Briplatin. After drug was administered, patient experienced the following side effects: anaemia, lymphocyte count decreased, malignant neoplasm progression, myelodysplastic syndrome, neutrophil count decreased, platelet count decreased, reflux oesophagitis, renal impairment, white blood cell count decreased. Briplatin dosage: unknown. During the same period patient was treated with PARAPLATIN, ALIMTA, GEMZAR, PANVITAN, CYANOCOBALAMIN, TAKEPRON, KYTRIL, DECADRON. Patient was hospitalized and became disabled. Patient died on 12/07/2007.

Briplatin Side Effects Report #5444861-6
Briplatin side effect was reported by a Health Professional from JAPAN on Sept 03, 2007. Female patient, 49 years of age, was diagnosed with ovarian cancer and was treated with Briplatin. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myelodysplastic syndrome. Briplatin dosage: unknown. During the same period patient was treated with VEPESID, ENDOXAN, ADRIAMYCIN PFS, IRINOTECAN. Patient died on 04/02/2004.


Briplatin Side Effects Report #5453766-6
Briplatin side effect was reported by a Health Professional from JAPAN on Sept 12, 2007. Female patient, 58 years of age, was diagnosed with hepatic mass and was treated with Briplatin. After drug was administered, patient experienced the following side effects: interstitial lung disease, malignant neoplasm progression, neoplasm recurrence. Briplatin dosage: unknown. During the same period patient was treated with VEPESID, ADRIAMYCIN RDF, CYCLOPHOSPHAMIDE, VINCRISTINE SULPHATE, FLUOROURACIL. Patient died.

Briplatin Side Effects Report #5474443-1
Briplatin side effect was reported by a Health Professional from JAPAN on Sept 27, 2007. Female patient, 58 years of age, was diagnosed with hepatic mass and was treated with Briplatin. After drug was administered, patient experienced the following side effects: interstitial lung disease, malignant neoplasm progression, neoplasm recurrence. Briplatin dosage: unknown. During the same period patient was treated with VEPESID, ADRIAMYCIN RDF, CYCLOPHOSPHAMIDE, VINCRISTINE SULPHATE, FLUOROURACIL, RANDA. Patient died.

Briplatin Side Effects Report #4544857-2
Briplatin side effect was reported by a Physician from on Dec 27, 2004. Male patient, 55 years of age, was treated with Briplatin. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, stomatitis. Briplatin dosage: unknown. During the same period patient was treated with DECADRON, THIOSULPHATE. Patient died on 11/24/2004.